ALPIX — Pixium Vision SA Share News
0.000.00%
Last trade - 00:00- €0.52m
- €5.28m
- €1.96m
Brief: Pixium Vision: opening of judicial liquidation proceedings has been postponed to later date
Brief: Pixium Vision Announces Decision About Adoption Of Sale Plan, Opening Of Judicial Liquidation Proceedings Planned For Jan 16, 2024
Brief: Pixium Vision SA Announces Conversion Of Safeguard Proceedings Into Receivership
Brief: Pixium Vision Announces Tender Process For Purpose Of Finding Buyers To Acquire Company's Business Will Be Published Tomorrow
Brief: Pixium Vision SA - Pixium Vision Announces Opening Of Safeguard Proceedings
Brief: Pixium Vision SA Announces Completion Of Reverse Stock Split Of Its Shares On Basis Of 1 New Share For 50 Existing Shares
Brief: Pixium Vision Announces Agreement To Extend Maturity Date Of Outstanding Notes Associated With ESGO Financing Facility
Brief: Pixium Vision Announces Tax Credit Receipt Of EUR 1.8 Mln From French Government
Brief: Pixium Vision Posts 2022 Operating Loss Of EUR 11.9 Mln
Brief: Pixium Vision Reports ESGO's Conversion Of 160 Ornan2022
Brief: Pixium Vision Announces FDA Granted Breakthrough Device Designation For Prima System
Brief: Pixium Vision Reduces Share Capital Due To Losses By Reducing Nominal Value
Brief: Pixium Vision Reports Cash Position Of EUR 7.7 Mln At 31 December 2022
Brief: Pixium Vision: Peer-Reviewed Publications Demonstrating Potential Of Next Generation Prima Implant
Brief: Pixium Vision Welcomes Judgment By Paris Commercial Court Against Second Sight Medical Products
Brief: Pixium Vision End-Sept Cash Position Down At 8.5 Million Euros
Brief: Pixium Vision Announces Publication Of Peer-Reviewed Clinical Data Of Prima System In Dry AMD in Journal Of Neural Engineering
Brief: Pixium Vision Announces Reaching Its Enrollment Target In European Pivotal Trial Primavera
Brief: Pixium Vision: Implantation Of First Patient In Italy In Prima System European Pivotal Trial Primavera